These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 31298937)

  • 1. The evolution of nasopharyngeal carcinoma staging.
    Guo R; Mao YP; Tang LL; Chen L; Sun Y; Ma J
    Br J Radiol; 2019 Oct; 92(1102):20190244. PubMed ID: 31298937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.
    Zhang Y; Zhang ZC; Li WF; Liu X; Liu Q; Ma J
    Oral Oncol; 2019 Aug; 95():150-156. PubMed ID: 31345383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of MRI-determined cervical lymph node size in nasopharyngeal carcinoma.
    Huang CL; Chen Y; Guo R; Mao YP; Xu C; Tian L; Liu LZ; Lin AH; Sun Y; Ma J; Tang LL
    Cancer Med; 2020 Oct; 9(19):7100-7106. PubMed ID: 32794334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma.
    Zeng L; Zhang Q; Ao F; Jiang CL; Xiao Y; Xie HH; Tang YQ; Gong XC; Li JG
    Auris Nasus Larynx; 2019 Jun; 46(3):457-464. PubMed ID: 30528104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx.
    Ai QY; King AD; Poon DMC; Mo FKF; Hui EP; Tong M; Ahuja AT; Ma BBY; Chan ATC
    Oral Oncol; 2019 Jan; 88():124-130. PubMed ID: 30616782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added value of metastatic cervical lymph node group V in nodal staging of nasopharyngeal cancer.
    Setakornnukul J; Thephamongkhol K; Chaysiri P
    Head Neck; 2020 Oct; 42(10):2801-2810. PubMed ID: 32542997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y
    Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Pan JJ; Ng WT; Zong JF; Chan LL; O'Sullivan B; Lin SJ; Sze HC; Chen YB; Choi HC; Guo QJ; Kan WK; Xiao YP; Wei X; Le QT; Glastonbury CM; Colevas AD; Weber RS; Shah JP; Lee AW
    Cancer; 2016 Feb; 122(4):546-58. PubMed ID: 26588425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasis of nasopharyngeal carcinoma to parotid lymph nodes: a retrospective study.
    Wang S; Lou J; Zhang S; Guo L; Wang K; Ge M
    World J Surg Oncol; 2015 Jan; 13():1. PubMed ID: 25622525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Zeng YY; Xiang ZZ; He T; Liu F; Shao BF; Yan RN; Ma JC; Wang XR; Liu L
    Oral Oncol; 2020 Dec; 111():104924. PubMed ID: 32736209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of the Chinese staging system for nasopharyngeal carcinoma.
    Zong J; Huang Q; Guo Q; Pan J
    Chin Clin Oncol; 2016 Apr; 5(2):19. PubMed ID: 27121879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.
    Li WF; Sun Y; Mao YP; Chen L; Chen YY; Chen M; Liu LZ; Lin AH; Li L; Ma J
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):249-56. PubMed ID: 23200171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of quantitative metastatic lymph node burden on magnetic resonance imaging in nasopharyngeal carcinoma: A retrospective study of 1224 patients from two centers.
    Ma H; Liang S; Cui C; Zhang Y; Xie F; Zhou J; Dong A; Chen M; Xie C; Li H; Liu L
    Radiother Oncol; 2020 Oct; 151():40-46. PubMed ID: 32679310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging.
    Mao YP; Liang SB; Liu LZ; Chen Y; Sun Y; Tang LL; Tian L; Lin AH; Liu MZ; Li L; Ma J
    Clin Cancer Res; 2008 Nov; 14(22):7497-503. PubMed ID: 19010867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is elective irradiation of lymph node levels IV and Vb necessary in nasopharyngeal carcinoma?].
    Semrau S; Haderlein M
    Strahlenther Onkol; 2022 Nov; 198(11):1042-1044. PubMed ID: 35951036
    [No Abstract]   [Full Text] [Related]  

  • 17. De-escalating elective nodal irradiation for nasopharyngeal carcinoma.
    Miller JA; Beadle BM; Gensheimer MF; Le QT
    Lancet Oncol; 2022 Apr; 23(4):441-443. PubMed ID: 35240054
    [No Abstract]   [Full Text] [Related]  

  • 18. Staging of nasopharyngeal carcinoma--the past, the present and the future.
    Ng WT; Yuen KT; Au KH; Chan OS; Lee AW
    Oral Oncol; 2014 Jun; 50(6):549-54. PubMed ID: 23838426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior cervical lymph node metastasis as the valuable prognostic factor for stage IVA/IVB nasopharyngeal carcinoma treated with induction chemotherapy followed by concurrent chemo-radiotherapy.
    Thephamongkhol K; Setakornnukul J; Rojwatkarnjana S; Chansilpa Y
    Int J Biol Markers; 2014 Dec; 29(4):e387-94. PubMed ID: 25198554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of the post-radiotherapy
    Jeong Y; Jung IH; Kim JS; Chang SK; Lee SW
    Br J Radiol; 2019 Oct; 92(1102):20180045. PubMed ID: 30102562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.